<2> Controversial Breast Cancer Treatment Raises Concerns Over Mortality Rates
<3> The Alarming Truth About a Prominent Treatment Method
<4> Invasive breast cancer is a prevalent health issue affecting millions of women worldwide, with the United States being no exception. According to the World Health Organization (WHO), roughly 1 in 8 US women are expected to be diagnosed with invasive breast cancer at some point in their lives. This makes breast cancer the most common cancer in women, excluding skin cancers. However, a recent study has shed light on a controversial breast cancer treatment that has sparked intense debate among medical professionals and patients alike.
<5> The Treatment in Question: Herceptin
<6> Herceptin, also known as trastuzumab, is a monoclonal antibody treatment that targets HER2-positive breast cancer cells. HER2-positive breast cancer is a type of cancer that is characterized by the overexpression of the HER2 protein on the surface of cancer cells. Herceptin works by binding to the HER2 protein, thereby inhibiting the growth and spread of cancer cells.
<7> The Controversy Surrounding Herceptin
<8> While Herceptin has been shown to be effective in treating HER